Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials.
Chest. 1996 Jul;110(1):62-70. doi: 10.1378/chest.110.1.62.
Chest. 1996.
PMID: 8681667